DUST CME FACULTY
DIRECTORS & KEYNOTE SPEAKER
Khurshid R. Ghani, M.B., B.Ch., MS
Associate Professor of Urology
Director, Michigan Urological
Surgery Improvement Collateral
University of Michigan
After receiving his medical degree from the University of Leeds, Dr. Ghani trained in urology in Edinburgh and London. He also has a Master of Surgery thesis from the University of London for research on percutaneous renal stone surgery. Following completion of his sub-specialist training in endourology and stone disease at Guys Hospital, London, he undertook a minimally invasive urologic surgery fellowship at Henry Ford Hospital, Detroit. He joined the University of Michigan faculty in 2013, and oversees the Endourology program at the Ann Arbor VA. Dr. Ghani has authored over 100 peer-reviewed publications and is the editor of Endourology: A Practical Handbook. He is the Course Director of the “Developments in Ureteroscopic Stone Treatment (DUST)” course, which focuses on the Dusting technique for laser stone surgery. Dr. Ghani is also the Co-Director of the Michigan Urological Surgery Improvement Collaborative, statewide consortium of over 40 urology practices focused at improving urological care in the state of Michigan.
William W. Roberts, M.D.
Professor of Urology
Chief, Division of Endourology
University of Michigan
Dr. William W. Roberts is a Professor of Urology and Biomedical Engineering at the University of Michigan. He earned a B.S. in Physics from the Massachusetts Institute of Technology in 1992, an M.D. from Johns Hopkins University School of Medicine in 1997, and pursued urology training at the Brady Urological Institute at the Johns Hopkins Hospital. In 2004, he joined the faculty at the University of Michigan, and is now Director of the Division of Endourology. His clinical practice is focused on endourology and stone disease. Dr. Roberts’ research interests include the exploration and translation of histotripsy, a noninvasive, nonthermal, focused ultrasound technology for tissue homogenization that was developed at the University of Michigan. He maintains strong collaborations with colleagues in the Department of Biomedical Engineering to support these efforts. This group was recently awarded the Kennedy Team Excellence Award from the College of Engineering. Dr. Roberts has presented his work at numerous international, national, and regional meetings and has authored over 100 peer-reviewed publications. His research contributions have also been recognized in the form of grants and awards from the National Institutes of Health, American Urological Association, The Engineering and Urology Society, Coulter Foundation, and the Kidney and Urology Foundation of America. He was the 2014 recipient of the prestigious AUA Gold Cystoscope Award.
Glenn M. Preminger, MD
James F. Glenn Professor of Urology
Chief, Division of Urological Surgery
Duke University Medical Center
Dr. Preminger’s clinical interests include the minimally invasive management of urinary tract stones, including shock wave lithotripsy, percutaneous, and ureteroscopic stone removal. He completed his training at the University of North Carolina in 1983 and was an American Urological Association Scholar (1983-1985) in the Division of Mineral Metabolism at the University of Texas Southwestern Medical Center, Dallas. In 1993, Dr. Preminger returned to North Carolina as professor of urological surgery and director of the Duke Comprehensive Kidney Stone Center.
Cecilia Cracco, MD, PhD
Department of Urology
Dr. Cracco worked in the Department of Urology at Hospital of Savigliano (Cuneo, Italy) for two years before moving to the Department of Urology of the University Hospital of Orbassano (Torino, Italy) with professor R. M. Scarpa for ten years. For the last three years, she has been in an academic position as researcher in Urology. She has worked in the Department of Urology of the Cottolengo Hospital of Torino (Italy) with Dr. C. M. Scoffone since 2011. Dr. Cracco has experience in the endourologic field, has taught urology residents, given presentations at a number of conferences, and has written a variety of national and international publications and invited book chapters. She is a member of the Italian Society of Urology, has received research grants, and participated in various clinical research protocols in GCP. She has been collaborating for years with Dr. C. M. Scoffone on the topic of ECIRS (also editing a Springer book on this topic), contributing to its diffusion, standardization and popularization, and has worked with him to organize advanced courses in Endourology.
NORTH AMERICAN FACULTY
Jodi Antonelli, M.D.
Assistant Professor of Urology
University of Texas Southwestern
Endourologist Jodi Antonelli, M.D., is an Assistant Professor in the Department of Urology at UT Southwestern Medical Center. She specializes in the medical and surgical management of kidney stone disease.
Dr. Antonelli earned her medical degree from Jefferson Medical College of Thomas Jefferson University. She completed a general surgery internship and a urology residency at Duke University Medical Center. She completed a fellowship in endourology and stone disease in the Department of Urology at UT Southwestern.
Her research interests include studying metabolic risk factors for kidney stones, particularly the role played by calcium. She is also collaborating with engineers from University of Texas to enhance the surgical instruments used for stone removal.
Dr. Antonelli is a member of the American Urological Association, the Endourological Society, and Alpha Omega Alpha Honor Medical Society.
Duane Baldwin, MD
Endourology Fellowship Director
Director of Research
Loma Linda University Health
Ben Chew, MD, MSc, FRCSC
Director of Clinical Research
Stone Centre at Vancouver General Hospital
Vancouver, British Columbia, Canada
Dr. Chew is a urologist and the Director of Clinical Research at the Stone Centre at Vancouver General Hospital and an Associate Professor of Urology at the University of British Columbia in Vancouver, Canada. His main interests lie in the treatment and research of the pathophysiology of kidney stone disease. His research focus includes metabolic stone disease as well as biomaterials used in the urinary tract for ureteral stents. He has worked on various stent designs, stent coatings and drug-eluting ureteral stents to try and improve the quality of life for patients with kidney stone disease. He continues work on a degradable ureteral stent and has completed the first-in-human trials. Current studies include attempting to understand second messenger systems that are activated within the kidney and ureter once a ureteral stent has been placed. These could be exploited as future therapeutic targets for new drug eluting ureteral stents or designs to reduce symptoms. He has authored over 80 peer-reviewed manuscripts and book chapters. He is a member of the Endourologic Disease Group for Excellence (EDGE) research consortium (www.endoedge.net)and the Wisconsin Quality of Life (WISQoL) research consortium. Dr. Ben Chew is also the Chair of Research for the Endourology Society. The role of the Research Chair is to facilitate and help improve research for the entire society.
Tom Chi, M.D.
Associate Chair, Clinical Affairs
University of California, San Francisco
Dr. Thomas Chi, MD, graduated as a President’s Scholar from Stanford University with a Bachelor of Arts in Human Biology as well as Masters degrees in both Sociology and Music. He went on to earn his medical degree from the University of California, San Francisco School of Medicine. After graduating, he completed two years of general surgery residency training and then a urology residency at UCSF. After completing his Chief Resident year in the Department of Urology, he continued on to finish a fellowship in Endourology and Laparoscopy under the mentorship of Dr. Marshall L. Stoller.
During his fellowship, Dr. Chi was awarded grant funding from the National Institutes of Health and the American Urological Association Urology Care Foundation to research the fundamental mechanisms underlying the formation of urinary stones. During that time he developed a novel model for the study of kidney stones utilizing the common fruit fly, Drosophila melanogaster.
He joined the UCSF faculty of the Department of Urology in 2013 where his clinical interests include the care of patients with urinary stone disease, benign prostatic hypertrophy (BPH) and those in need of minimally invasive surgery. He specializes in the performance of endoscopic, laparoscopic, and percutaneous surgeries. Dr. Chi has used ultrasound guidance to create innovative radiation-free kidney stone surgeries for stone removal, representing the first program of its kind in the United States. He is also experienced in performing Holmium Laser Enucleation of the Prostate (HoLEP) – a minimally invasive operation to treat men with an enlarged prostate. He has established ReSKU, the Registry for Stones of the Kidneys and Ureter, the first kidney stone registry of its kind for tracking patient clinical outcomes and is an internationally recognized specialist in the use of ultrasound in the management of kidney stones to minimize patient radiation exposure.
In addition to his clinical interests, Dr. Chi supervises an NIH-funded translational science lab (click hereto be directed to Dr. Chi’s lab website) where he leads a cross-disciplinary research team. His research focuses on understanding the genetic and microbial environment of the kidney related to how kidney stones form and developing new medical preventative interventions. He has published over 50 peer-reviewed articles and book chapters spanning both basic science as well as epidemiologic approaches centered around improving the care of patients with urinary stone disease.
Casey A. Dauw, M.D.
Assistant Professor, Urology
University of Michigan
Dr. Dauw received his medical degree from Loyola University in Chicago graduating Magna Cum Laude. He then completed a urology residency at The University of Michigan. Following this, he pursued subspecialty training in endourology with Dr. James Lingeman at Methodist Hospital in Indianapolis. His primary clinical interests include the medical and surgical management of kidney stones, in particular, endourological management of complex renal calculi. He is also one of few U.S. providers with expertise in holmium laser enucleation of the prostate (HoLEP), a state-of-the-art, minimally invasive surgical treatment for men with an enlarged prostate. His research interests focus on improving the quality of care for patients with kidney stones as well as understanding outcomes associated with commonly performed endourological surgeries.
Michael Lipkin, M.D., MBA
Associate Professor Urologic Surgery
Chief of the Clinics, Department of Surgery
Duke University Medical Center
Dr. Lipkin received his medical degree from New Jersey Medical School in 2003. He completed his urology residency at New York University Medical Center in 2009. In 2011, he completed an Endourology and Minimally Invasive Urologic Surgery Fellowship with Dr. Glenn Preminger at Duke University Medical Center. His main clinical and academic interests are in the surgical and medical management of kidney stones. His particular research focus is in patient radiation exposure and urologic imaging. He has over 30 peer-reviewed manuscripts and has co-authored several chapters. He was awarded for Best of AUA for an abstract on stone disease in 2012. He also was awarded for Best Endourology Presentation at the World Congress of Endourology in 2012.
Michelle Semins, MD
University of Pittsburgh
School of Medicine
Director of UPMC
Kidney Stone Center
Dr. Michelle Jo Semins is an Assistant Professor and Urologic Surgeon in the Department of Urology and Director of the Kidney Stone Clinic at Mercy Hospital. She received her undergraduate degree from The University of Michigan and her medical degree from the University of Pittsburgh School of Medicine. She then completed her internship in surgery and residency urology training at Johns Hopkins Hospital with additional specialty training in the field of endourology. Dr. Semins is a current board member of the Northeastern Section of the AUA, and is a member of the American Urological Association, Society of Endourology, the Pittsburgh Urological Society, Research on Calculus Kinetics Society, and the Society of Women in Urology. She has a clinical research focus in kidney stones and is a past awardee of a Young Investigator Research Grant by the Northeastern Section of the AUA. She was also named the Young Urologist of the Year by the AUA in 2016. Dr. Semins is a reviewer for the Journal of Urology and many other peer-review journals. She is a published author of over 40 articles, over 50 abstracts, and 9 book chapters.
Ojas Shah, MD
George F. Cahill Professor of Urology
Columbia University College of Physicians and Surgeons
Director, Division of Endourology and Stone Disease at Columbia University Medical Center
Dr. Ojas Shah is a nationally and internationally recognized expert in the medical and surgical management of patients with urinary stone disease. He serves as the Director of the Division of Endourology and Stone Disease at Columbia University Irving Medical Center in New York as well as the Director of the Fellowship in Endourology. He is the principal investigator of many clinical research trials regarding the surgical or medical management of stone disease. Dr. Shah is a member of the American Board of Urology Examination Committee and served on the AUA Guidelines Committee for the Surgical Management of Stone Disease. He also recently completed his term as Assistant Editor for the Journal of Urology and is co-editor of the textbook Taneja’s Complications of Urologic Surgery.
Dr. Shah is a graduate of the Honors Program in Medical Education at Northwestern University School of Medicine. He completed his urologic training at New York University Medical Center. He spent an additional year at Wake Forest University Health Sciences Center as a fellow in endourology, laparoscopy and metabolic stone disease.
Roger Sur, MD
Director, Comprehensive Kidney Stone Center
Professor of Urology
University of California San Diego
Roger Sur, MD, is a board-certified urologist and director of the Comprehensive Kidney Stone Center at UC San Diego Health. He completed an endourology society fellowship at Duke University Medical Center training under a world renowned kidney stone specialist. Dr. Sur seeks to bring a world class kidney stone center to the SouthWest United States that will focus on surgical treatment, medical prevention, and research into causes of kidney stones. It is the only center of its kind here in Southern California dedicated to patients suffering from kidney stones. Additionally, having performed more than 100 robotic cases, Dr. Sur also brings a wealth of experience to patients seeking robotic surgery. He served 20 years as a naval physician in numerous overseas deployments and currently is a reservist at Naval Medical Center San Diego. Dr. Sur is a professor in the Department of Urology at UC San Diego School of Medicine, and serves as the program director for the Laparoscopic/Endourology Fellowship Program. He is also an associate professor of Surgery at the military medical school, Uniformed Services University of the Health Sciences. Dr. Sur has published numerous manuscripts and books and serves as content reviewer for the American Urological Association.
Joel Teichman, M.D., FRCSC
Professor, Department of Urologic Sciences
University of British Columbia
Vancouver, British Columbia, Canada
Dr. Teichman specializes in endourology and interstitial cystitis. His primary interests in endourology relate to kidney stones and laser-stone interactions. Ongoing research has focused on understanding the performance characteristics of optical fibers used for holmium:YAG lithotripsy, and the development of improved optical fibers; parameters of mid-infrared lasers for optimal stone fragmentation; the potential application of femtosecond laser ablation. He has current projects on the basic science of laser lithotripsy in collaboration with biomedical optics researchers at the University of Texas, Austin, and laser fiber testing in collaboration with urologists at the Ohio State University, Columbus. His primary interests in interstitial cystitis relate to clinical diagnosis and presentation of patients, often diagnosed after years of symptoms and multiple misdiagnoses. Recent publications have included the interstitial cystitis and dyspareunia, intravesical medication treatment for interstitial cystitis, and the impact of sex abuse on interstitial cystitis. Dr. Teichman is participating in a multicenter trial for a novel urine diagnostic test for interstitial cystitis.
J. Stuart Wolf Jr., MD
Associate Chair of Clinical Integration and Operations
Department of Surgery and Perioperative Care
Professor, Department of Surgery and Perioperative Care
University of Texas Austin
Stuart Wolf is associate chair of clinical integration and operations and professor for the Department of Surgery and Perioperative Care. After receiving his M.D. from Northwestern University, Wolf completed urology residency at UCSF and then an endourology/laparoscopy fellowship with Ralph Clayman. He joined the University of Michigan in 1996 and over the ensuing 20 years he served as the director of the Division of Endourology, the director of the endourology/laparoscopy fellowship and the associate urology department chair for surgical services. In 2016, he assumed his current role as associate chair for clinical integration and operations of the Department of Surgery and Perioperative Care at Dell Medical School. Wolf has served on the executive committee of the Michigan Urologic Society and the board of directors of the Endourological Society. He formerly chaired the AUA Practice Guidelines Committee and is the inaugural chair of the AUA Science and Quality Council. At the University of Michigan, Wolf received the Silver Cystoscope Award for Urology Residency Teaching Excellence three times (1999, 2002 and 2005). He was appointed the inaugural David A. Bloom Professor of Urology in 2006. The Department of Urology awarded him the Faculty Service Award in 2011 and the Outstanding Achievement Award in 2012. He was inducted into the League of Educational Excellence of the University of Michigan Medical School in 2015 and that year he received the Program Director’s Award from the Endourological Society. In 2010, Wolf was elected to the American Association of Genitourinary Surgeons. In 2018, he started a six-year term as a trustee of the American Board of Urology. Early in Wolf’s career, he garnered extramural funding for basic science research but then his interests moved to clinic research. His most recent work focuses on urinary calculi, kidney cancer, upper urinary tract obstruction and a variety or quality improvement and patient safety topics. An author of more than 300 peer-reviewed articles and videos, and more than 150 invited publications, Wolf has served on the editorial boards of 11 journals. His scholarly work has been recognized by awards and/or research grants from the American Foundation for Urologic Disease, the Department of Veterans Affairs, the Endourological Society, the American Society of Transplant Surgeons, and the AUA and 2 of its Sections. He is currently ranked number 84 in the field of Urology (all-time) on the Microsoft Academic Author Analytics website.